Cargando…

Recent advances of pharmacogenomics in severe cutaneous adverse reactions: immune and nonimmune mechanisms

Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and drug reaction with eosinophilia and systemic symptoms (DRESS) are severe cutaneous adverse reactions (SCAR) which are majorly caused by drugs. Though the incidence rate is low, SCAR sometimes can be life-threatening and leads to l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dao, Ro-Lan, Su, Shih-Chi, Chung, Wen-Hung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asia Pacific Association of Allergy, Asthma and Clinical Immunology 2015
Materias:	Current Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415181/ https://www.ncbi.nlm.nih.gov/pubmed/25938070 http://dx.doi.org/10.5415/apallergy.2015.5.2.59

Ejemplares similares

Severe Cutaneous Adverse Reactions: The Pharmacogenomics from Research to Clinical Implementation
por: Su, Shih-Chi, et al.
Publicado: (2016)

Cytotoxic Proteins and Therapeutic Targets in Severe Cutaneous Adverse Reactions
por: Su, Shih-Chi, et al.
Publicado: (2014)

Recent Advances in Severe Cutaneous Adverse Drug Reaction
por: Das, Sudip, et al.
Publicado: (2018)

The pharmacogenomics of carbamazepine-induced cutaneous adverse drug reaction in the South of Vietnam
por: Nguyen, Ai-Hoc, et al.
Publicado: (2023)

Genetics of Severe Cutaneous Adverse Reactions
por: Yang, Shang-Chen, et al.
Publicado: (2021)

Pharmacogenomics of adverse drug reactions
por: Daly, Ann K
Publicado: (2013)

Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies
por: Chen, Chun-Bing, et al.
Publicado: (2018)

A Comprehensive Review of HLA and Severe Cutaneous Adverse Drug Reactions: Implication for Clinical Pharmacogenomics and Precision Medicine
por: Kloypan, Chiraphat, et al.
Publicado: (2021)

Drug-Induced Severe Cutaneous Adverse Reactions: Insights Into Clinical Presentation, Immunopathogenesis, Diagnostic Methods, Treatment, and Pharmacogenomics
por: Tempark, Therdpong, et al.
Publicado: (2022)

Pharmacogenetic Testing for Prevention of Severe Cutaneous Adverse Drug Reactions
por: Chang, Chih-Jung, et al.
Publicado: (2020)

Pharmacogenomics and adverse drug reactions in children
por: Rieder, Michael J., et al.
Publicado: (2014)

Editorial: Pharmacogenomics of Adverse Drug Reactions
por: Siddiqui, Moneeza K., et al.
Publicado: (2022)

An Updated Review of Genetic Associations With Severe Adverse Drug Reactions: Translation and Implementation of Pharmacogenomic Testing in Clinical Practice
por: Wang, Chuang-Wei, et al.
Publicado: (2022)

Genophenotypic Factors and Pharmacogenomics in Adverse Drug Reactions
por: Cacabelos, Ramón, et al.
Publicado: (2021)

Treatments for Severe Cutaneous Adverse Reactions
por: Cho, Yung-Tsu, et al.
Publicado: (2017)

Cutaneous adverse drug reactions induced by Oxcarbazepine
por: Hsiao, Yi-Hsin, et al.
Publicado: (2014)

Genetic markers of severe cutaneous adverse reactions
por: Jung, Jae-Woo, et al.
Publicado: (2018)

The assessment of severe cutaneous adverse drug reactions
por: Copaescu, Ana M, et al.
Publicado: (2022)

Chemokines in Severe Cutaneous Adverse Reactions (SCARs)
por: Miyagawa, Fumi, et al.
Publicado: (2021)

Recent advances in CRISPR research
por: Chen, Baohui, et al.
Publicado: (2020)

Malignant Melanoma and Its Stromal Nonimmune Microecosystem
por: Piérard, Gérald E., et al.
Publicado: (2012)

Thoracic Ganglioneuromas Resulting in Nonimmune Hydrops Fetalis
por: Singh, Paul, et al.
Publicado: (2014)

Review on Databases and Bioinformatic Approaches on Pharmacogenomics of Adverse Drug Reactions
por: Tong, Hang, et al.
Publicado: (2021)

A pharmacogenomic assessment of psychiatric adverse drug reactions to levetiracetam
por: Campbell, Ciarán, et al.
Publicado: (2022)

The Apportionment of Pharmacogenomic Variation: Race, Ethnicity, and Adverse Drug Reactions
por: Jordan, I. King, et al.
Publicado: (2022)

Identification of drug-specific public TCR driving severe cutaneous adverse reactions
por: Pan, Ren-You, et al.
Publicado: (2019)

Cutaneous Adverse Reactions of Immunotherapy in Patients with Advanced Melanoma
por: Nikolaou, Vasiliki, et al.
Publicado: (2023)

Immunohistopathological Findings of Severe Cutaneous Adverse Drug Reactions
por: Orime, Mari
Publicado: (2017)

Risk factors of mortality in severe cutaneous adverse reactions patients with pulmonary involvement
por: Hu, H, et al.
Publicado: (2012)

Optimizing the Intensive Care Treatment of Severe and Complicated Plasmodium falciparum Malaria in Nonimmune Patients
por: Chentsov, V. B., et al.
Publicado: (2020)

New Insights into the Function of the Immunoproteasome in Immune and Nonimmune Cells
por: Kimura, Hiroaki, et al.
Publicado: (2015)

Nonimmune hydrops fetalis secondary to aneurysm of the vein of Galen
por: Attuveppil, Vijayalakshmy Raman, et al.
Publicado: (2008)

Nonspecificity in a nonimmune human scFv repertoire
por: Kelly, Ryan L., et al.
Publicado: (2017)

Meconium Peritonitis Presenting with Nonimmune Hydrops and Mirror Syndrome
por: Mishra, Purbasha, et al.
Publicado: (2022)

Blackwater Fever Treated with Steroids in Nonimmune Patient, Italy
por: Di Biase, Anna Rita, et al.
Publicado: (2023)

Digging Up the Human Genome: Current Progress in Deciphering Adverse Drug Reactions
por: Su, Shih-Chi, et al.
Publicado: (2014)

Recent Advances in Preventing Adverse Reactions to Transfusion
por: Rogers, Thomas S, et al.
Publicado: (2015)

Single-Cell Sequencing Unveils the Heterogeneity of Nonimmune Cells in Chronic Apical Periodontitis
por: Lin, Xinwei, et al.
Publicado: (2022)

Multiple drug hypersensitivity associated with severe cutaneous adverse reaction
por: Lin Choo, Karen Jui, et al.
Publicado: (2014)

Analysis of B cell subsets in severe cutaneous adverse reaction
por: Azukizawa, Hiroaki, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_d21c6qljstfhf8jjt0qc3eaggg